Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Synguton Apr 04, 2015 12:24pm

83 Views

Post# 23596847

RE:Will FDA palms need to be greased?

Imagine them number of pharmaceutical companies that could be affected with TLT's FDA approval?

A report said that 22% of all cancer claims use chemotherapy drugs, and that ... of the global pharmaceutical market, potentially reaching $80 billion by 2012.

that's a lot of influence!

Bullboard Posts

Investors eye Australian gold mining projects amid promising developments